Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2266403rdf:typepubmed:Citationlld:pubmed
pubmed-article:2266403lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2266403lifeskim:mentionsumls-concept:C0008300lld:lifeskim
pubmed-article:2266403lifeskim:mentionsumls-concept:C0220655lld:lifeskim
pubmed-article:2266403lifeskim:mentionsumls-concept:C0055618lld:lifeskim
pubmed-article:2266403pubmed:issue12lld:pubmed
pubmed-article:2266403pubmed:dateCreated1991-2-14lld:pubmed
pubmed-article:2266403pubmed:abstractTextA 68-yr-old male with agnogenic myeloid metaplasia was given phosphorus-32-colloidal chromic phosphate intrapericardially for the treatment of malignant pericardial effusion. Technetium-99m-sulfur colloid was used to verify catheter placement and to visualize distribution within the pericardium. Estimated dosimetry for this mode of therapy is presented, and it is suggested that pericardial administration of phosphorus-32-colloidal chromic phosphate is the treatment of choice for malignant pericardial effusion.lld:pubmed
pubmed-article:2266403pubmed:languageenglld:pubmed
pubmed-article:2266403pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:citationSubsetIMlld:pubmed
pubmed-article:2266403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2266403pubmed:statusMEDLINElld:pubmed
pubmed-article:2266403pubmed:monthDeclld:pubmed
pubmed-article:2266403pubmed:issn0161-5505lld:pubmed
pubmed-article:2266403pubmed:authorpubmed-author:Sprengelmeyer...lld:pubmed
pubmed-article:2266403pubmed:authorpubmed-author:McDermottR...lld:pubmed
pubmed-article:2266403pubmed:issnTypePrintlld:pubmed
pubmed-article:2266403pubmed:volume31lld:pubmed
pubmed-article:2266403pubmed:ownerNLMlld:pubmed
pubmed-article:2266403pubmed:authorsCompleteYlld:pubmed
pubmed-article:2266403pubmed:pagination2034-6lld:pubmed
pubmed-article:2266403pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:meshHeadingpubmed-meshheading:2266403-...lld:pubmed
pubmed-article:2266403pubmed:year1990lld:pubmed
pubmed-article:2266403pubmed:articleTitlePhosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion.lld:pubmed
pubmed-article:2266403pubmed:affiliationNuclear Medicine Dept., Kaiser Foundation Hospital, West Los Angeles, CA 90034.lld:pubmed
pubmed-article:2266403pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2266403pubmed:publicationTypeCase Reportslld:pubmed